acut
respiratori
distress
syndrom
ard
common
complic
critic
ill
injuri
associ
signific
morbid
mortal
pathogenesi
ard
involv
mechan
inflammatori
injuri
lung
caus
mark
derang
alveolarcapillari
permeabl
passag
proteinrich
edema
fluid
air
space
ard
usual
occur
context
uncontrol
respons
local
system
inflamm
recent
two
endotyp
ardsnam
hyperinflammatori
hypoinflammatoryhav
identifi
differ
therapeut
respons
prognos
clinic
pathogenesi
often
multifactori
complex
interact
risk
factor
risk
modifi
fig
sepsi
pneumonia
shock
common
condit
predispos
ard
howev
minor
patient
disord
actual
ard
fig
typic
predispos
condit
includ
gastropulmonari
aspir
trauma
massiv
blood
product
transfus
atyp
respiratori
infect
includ
viral
influenza
fungal
pneumocysti
jiroveci
histoplasma
spp
blastomyc
spp
infect
unusu
import
caus
ard
especi
patient
compromis
immun
system
sever
pathogen
sever
acut
respiratori
syndrom
sar
middl
east
respiratori
syndromecoronaviru
epidem
influenza
attract
widespread
attent
confer
increas
risk
ard
addit
patient
risk
factor
includ
gastroesophag
reflux
diseas
chronic
silent
aspir
drug
exposur
observ
studi
clinic
trial
note
distinct
subtyp
ard
without
known
risk
factor
note
patient
may
better
prognos
certain
host
genet
variant
associ
develop
sepsi
ard
includ
mutat
surfact
protein
b
recent
genomewid
associ
studi
compar
africanamerican
patient
ard
atrisk
control
subject
identifi
selectin
p
ligand
gene
selplg
novel
ard
suscept
gene
genet
associ
gener
difficult
replic
role
genet
predisposit
develop
ard
present
unclear
sepsi
alcohol
associ
distinctli
high
risk
ard
chronic
alcohol
use
carri
twofold
threefold
increas
ard
develop
exact
mechan
associ
remain
unknown
may
relat
reduct
antioxid
capac
lung
addit
acut
chronic
consumpt
alcohol
caus
increas
system
level
adenosin
dosedepend
reduct
alveolar
fluid
clearanc
stimul
adenosin
type
receptor
ad
lung
injuri
studi
trauma
patient
demonstr
risk
ard
increas
direct
proport
blood
alcohol
content
histori
tobacco
exposur
includ
secondhand
smoke
associ
increas
risk
ard
trauma
patient
anoth
studi
found
independ
doserespons
associ
current
cigarett
smoke
subsequ
develop
ard
hypoalbuminemia
wellknown
marker
acut
chronic
ill
malnutrit
poor
surgic
outcom
also
found
independ
risk
factor
ard
appear
mediat
decreas
plasma
oncot
pressur
increas
pulmonari
permeabl
critic
ill
independ
underli
caus
fluid
statu
hypercapn
acidosi
protect
ventilatorinduc
lung
injuri
sever
anim
model
ard
howev
low
ph
particular
metabol
acidosi
associ
increas
risk
ard
obes
also
independ
risk
factor
develop
ard
although
effect
bodi
posit
compress
atelectasi
may
part
explain
observ
associ
addit
mechan
propos
includ
imbal
proinflammatori
antiinflammatori
cytokin
increas
lung
inflamm
injuri
tumor
necrosi
factora
pathway
diabet
mellitu
seem
associ
lower
risk
ard
septic
shock
inde
metaanalysi
includ
total
adult
patient
suggest
diabet
protect
ard
although
exact
mechan
known
one
possibl
explan
diabet
patient
impair
activ
inflammatori
cascad
lung
altern
hypothesi
ard
pathogenesi
propos
suggest
surfact
dysfunct
may
critic
step
ard
progress
spontan
mechan
hyperventil
induc
surfact
dysfunct
lead
higher
surfac
tension
atelectasi
injuri
augment
supin
posit
sedat
effect
particularli
pronounc
obes
patient
howev
trial
administ
surfact
ard
patient
show
outcom
benefit
lung
injuri
predict
score
lip
creat
intent
facilit
design
conduct
ard
prevent
studi
model
includ
risk
factor
risk
modifi
present
time
hospit
admiss
ard
occur
later
valid
refin
hospit
patient
frequent
expos
variou
potenti
harm
factor
may
modifi
risk
ard
develop
compar
patient
die
caus
ard
deced
markedli
higher
incid
potenti
prevent
advers
event
medic
surgic
misadventur
high
tidal
volum
ventil
high
oxygen
concentr
plasma
transfus
multipar
femal
donor
implic
iatrogen
contributor
ard
septic
patient
delay
fluid
resuscit
initi
antimicrobi
treatment
also
associ
ard
although
lungprotect
mechan
ventil
consid
standard
care
patient
establish
ard
seri
studi
suggest
applic
mechan
ventil
patient
may
safe
benefici
larg
casecontrol
studi
found
iatrogen
risk
factor
significantli
greater
patient
ard
match
control
deem
factor
prevent
multipl
potenti
strategi
direct
prevent
ard
propos
includ
earli
identif
atrisk
patient
standard
clinic
practic
prevent
iatrogen
injuri
earli
treatment
predispos
condit
checklist
lung
injuri
prevent
clip
develop
ensur
complianc
evidencebas
practic
may
affect
ard
occurr
current
use
clinic
trial
ard
prevent
clip
item
includ
lungprotect
mechan
ventil
aspir
precaut
earli
adequ
antimicrobi
therapi
restrict
fluid
transfus
manag
earli
assess
extub
daili
awaken
breath
trial
populationbas
cohort
studi
conduct
olmst
counti
minnesota
report
decreas
incid
ard
case
per
personyear
case
per
personyear
decreas
ard
incid
observ
despit
stabl
incid
communityacquir
ard
increas
popul
sever
ill
comorbid
burden
predispos
condit
ard
time
period
decreas
attribut
prevent
strategi
describ
includ
lungprotect
ventil
strategi
mechan
ventil
patient
restrict
transfus
practic
maledonorpredomin
plasma
improv
sepsi
treatment
conserv
fluid
manag
although
sever
potenti
pharmacolog
therapi
emerg
target
specif
compon
underli
pathogen
pathway
ard
date
none
proven
effect
prevent
ard
recent
phase
iia
doubleblind
multicent
random
control
trial
rct
studi
feasibl
combin
inhal
corticosteroid
inhal
longact
betaadrenerg
agonist
patient
increas
risk
ard
lip
score
show
improv
oxygen
compar
placebo
although
intend
studi
effect
prevent
ard
lower
incid
ard
treatment
group
becam
nonsignific
adjust
shock
although
pilot
studi
limit
sampl
size
trial
help
inform
futur
studi
use
inhal
betaadrenerg
agonist
also
formal
evalu
phase
ii
rct
patient
undergo
esophagectomi
intraop
administr
inhal
salmeterol
reduc
sever
biomark
alveolar
inflamm
injuri
associ
decreas
incid
postop
advers
event
predominantli
pneumonia
howev
incid
ard
differ
group
administr
aspirin
thought
protect
earlier
observ
studi
howev
phase
ii
rct
compar
aspirin
placebo
patient
increas
risk
ard
lip
score
differ
incid
ard
import
outcom
howev
ancillari
mechanist
studi
demonstr
import
role
biomark
intravascular
monocyt
activ
potenti
prevent
effect
aspirin
ard
develop
perprotocol
analysi
anim
studi
suggest
statin
may
benefici
modul
hyperinflammatori
ard
howev
clinic
trial
patient
fail
demonstr
benefit
systemat
review
observ
studi
rct
shown
benefici
effect
statin
prevent
ard
highrisk
patient
sever
pharmacolog
therapi
prevent
ard
patient
risk
evalu
clinic
studi
includ
inhal
heparin
inhal
steroid
peroxisom
prolifer
receptor
antagonist
angiotensin
inhibitor
curcumin
vitamin
conclus
although
sepsi
pneumonia
shock
commonli
predispos
patient
ard
mani
risk
factor
potenti
modifi
earli
identif
risk
import
ongo
clinic
studi
evalu
variou
promis
prevent
strategi
meanwhil
attent
best
practic
avoid
iatrogen
exposur
simpl
power
strategi
reduc
burden
import
complic
critic
ill
sepsi
pneumonia
shock
common
condit
predispos
ard
certain
host
genet
variant
associ
develop
sepsi
ard
abus
alcohol
tobacco
predispos
ard
malnutrit
obes
lip
simplifi
earli
acut
lung
injuri
score
predict
ard
base
clinic
investig
criteria
hospitalacquir
ard
may
result
medley
factor
high
tidal
volum
ventil
high
oxygen
concentr
plasma
transfus
commonli
implic
checklist
lung
injuri
prevent
clip
develop
ensur
complianc
evidencebas
practic
may
affect
ard
occurr
date
pharmacolog
intervent
shown
prevent
ard
